News

Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key ...
Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...
The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...
Poison control centers across the US say they are seeing a steep increase in calls related to semaglutide, an injected medication used for diabetes and weight loss, with some people reporting ...
Americans desperate for the hot weight-loss drug Ozempic are turning to Canada and Mexico because they can't afford it at home. ... 9% of the 30,000 prescriptions for semaglutide, ...
Semaglutide, she says, was “the last piece of the puzzle. ... she couldn’t afford to have it done. Eventually, she flew to San Diego and crossed the border to Mexico, ...
In New Mexico, where Lambson is now the director of the state’s Poison and Drug Information Center, GLP-1–related calls have doubled every year since 2021. That trend holds up nationally.
Joseph Lambson, the director of the New Mexico Poison and Drug Information Center, said patients taking compounded semaglutide report receiving varying levels of counseling from pharmacists on how ...
The Kiran Mazumdar Shaw-led insulin maker is joining the leagues of the world’s largest generic drugmakers, which include ...
Poison control centers across the US say they are seeing a steep increase in calls related to semaglutide, an injected medication used for diabetes and weight loss, with some people reporting ...